Critical care 2017;21:74.
12. Kellum JA, Song M, Venkataraman R.
Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia.
Critical care medicine 2004;32:801-5.
13. David S, Thamm K, Schmidt BMW, Falk CS, Kielstein JT.
Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient.
J Intensive Care 2017;5:12.
14. Bowles CT, Ohri SK, Klangsuk N, Keogh BE, Yacoub MH, Taylor KM.
Endotoxaemia detected during cardiopulmonary bypass with a modified Limulus amoebocyte lysate assay.
Perfusion 1995;10:219-218.
15. Ohri SK, Velissaris T.
Gastrointestinal dysfunction following cardiac surgery.
Perfusion 2006;21:215-223.
16. Prabhu SD.
Cytokine-induced modulation of cardiac function.
Circulation Research 2004;95:1140-1153.
17. Complement activation in extracorporal circuits.
Chenoweth DE.
Annals of the New York Academy of Science 1987;516:306-313.
18. Lin E, Calvano SE, Lowry SF.
Inflammatory cytokines and cell response in surgery.
Surgery 2000;117:117-26.
19. Peng ZY, Carter MJ, Kellum JA.
Effects of hemoadsorption on cytokine removal and short-term survival in septic rats.
Crit Care Med.2008;36(5):1573-1577.
20. Whitlock RP, Teoh KH, Lamy A, Vincent J, Pogue J, Paparella D, Sessler DI, Karthikeyan G, Villar JC, Zuo Y, Avezum Á, Quantz M, Tagarakis GI, Shah PJ, Abbasi SH, Zheng H, Pettit S, Chrolavicius S, Yusuf S.
Methylpredisolon in patients undergoing cardiopulmonary bypass (SIRS): a randomized, double-blind, placebo-controlled trail.
Lancet 2015;386:1243-53.
21. Paparella D, Yau TM, Young E.
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.
European Journal of Cardio-thoracic Surgery 2002;21:232-244.
22. Rimmleé T, Kellum J.
Clinical review: Blood purification for sepsis.
Critical Care 2011;15:205-214.
23. Hildebrand F, Pape HC, Krettek C.
Die Bedeutung der Zytokine in der posttraumatischen Entzündungsreaktion.
Unfallchirurg 2005;108:793-803.
24. Andus T, Palitzsch KD, Gross V, Schölmerich J.
Metabolische und endokrine Funktion der Zytokine.
Dtsch.med.Wschr 1993;118:306-313.
25. Frauenberger P, Walli AK, Seidel D.
Stellenwert von Zytokinen in der Sepsis-Diagnostik.
Infusionsther.Transfusionsmed. 1996;23(suppl 4):109-116.
26. Loppnow H.
Zytokine: Klassifikation, Rezeptoren, Wirkungsmechanismen.
Internist 2001;42:13-27.
27. Biglioli P, Cannata A, Alamanni F, Naliato M, Porqueddu M, Zanobini M, Tremoli E, Parolari A.
Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress.
European Journal of Cardio-thoracic Surgery 2004;24:260-269.
28. Börgermann J, Scheubel RJ, Simm A, Silber RE, Friedrich I.
Inflammatory response in on- versus off-pump myocardial revascularization: is ecc really the culpit?
Thorac Cardiov Surg 2007;55:473-480.
29. Wan S, LeClerc JL, Vincent JL.
Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies.
Chest 1997;112.3:676-703.
30. Raja SG, Berg GA.
Impact of off-pump coronary artery bypass surgery on systemic inflammation: Current best available evidence.
Card Surg 2007;22:445-455.
31. Deppe AC, Arbash W, Kuhn EW, Slottosch I, Scherner M, Liakopoulos OJ, Choi YH, Wahlers T.
Current evidence of coronary artery bypass grafting off-pump versus on-pump: a systemic review with meta-analysis of over 16900 patients investigated in randomized controlled trials.
European Journal of Cardio-Thoracic Surgery 2016;49:1031-1041.
32. Wittwer T, Sabashnikov A, Rahmanian PB, Choi YH, Zeriouh M,Mehler TO, Wahler T.
Less invasive coronary artery revascularization with a minimized extracorporal
circulation system: preliminary result of a comparative study with off-pump-procedures.
Cardiothoracic Surgery 2013;8:75-84.
33. Linden K, Scaravilli V, Kreyer SFX, Belenkly SM, Stewart IJ, Chung KK, Cancio LC, Batchinsky AI.
Evaluation of the CytoSorbTM hemoadsorptive column in a pig model of severe smoke and burn injury.
Shock 2015;44,5:487-495.
34. Peng ZY, Bishop JV, Wen XY, Elder MM, Zhou F, Chuasuwan A, Carter MJ, Devlin JE, Kaynar AM, Singbartl K, Pike F, Parker RS, Clermont G, Federspiel WJ, Kellum JA.
Modulation of chemokine gradients by apheresis redirects leukocyte trafficking to different compartment during sepsis, studies in a rat model.
Critical Care 2014;18:R141-153.
35. Goepfert MS, Richter HP, Eulenburg Cz, Gruetzmacher J, Rafflenbeul E, Roeher K, Sandersleben A, Diedrichs S, Reichenspurner H, Goetz AE, Reuter DA.
Individually opimized hemodynamic therapy reduced complicazions and lenght of stay in the intensive care unit: A prospective, randomized controlled trial.
Anesthsiology 2013;119:824-836.
36. Hotchkiss RS, Monneret G, Payen D.
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.
Nat Rev Immunol.2013;13(12):862-874.
37. Hotchkiss RS, Karl IE.
The pathophysiology and treatment of sepsis.
N Engl J Med 2003;348:138-150.
38. Oohen J.
The immunopathogenesis of sepsis.
Nature 2002;420:885-891.
39. Pablo R, Monserrat J, Reyes E, Diaz-Martin D, Zapata MR, Carballo F, Hera A, Prieto A, Alvarez-Mon M.
Mortality in patients with septic shock correlates with anti-inflammatory immunomodulatory molecules.
Journal of Intensive Care Medicine 2011;26:125-132.
40. Grünenfelder J, Zünd G, Schoeberlein A, Maly FE, Schurr U, Guntle S, Fischer K, Turina M.
Modified ultrafiltration lower adhesion molecules and cytokine levels after cardiopulmonary bypass without clinical relevance in adults.
European Journal of Cardio-thoracic Surgery 2000;17:77-83.
41. Hirai S.
Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass.
Ann Thorac Cardiovasc Surg 2003;9:365-370.
42. Boldt J, Kumle B, Papsdorf M, Hempelmann G.
Are circulating adhesion molecules specifically changed in cardiac surgical patients?
Ann Thorac Surg 1998;65:608-614.
43. Schädler D, Porzelius C, Jörres A, Marx G, Meier-Hellmann A, Putensen C, Quintel M, Spies C, Engel C, Weiler N, Kuhlmann M.
A multicenter randomized controlled study of an extracorporal cytokine hemoadsorption device in septic patients.
Citical Care 2013;17(Suppl 2):62.
44. Boeken U, Feindt P.
Ist das SIRS/Sepsis-Syndrom in der Herzchirurgie Folge der extrakorporalen Zirkulation und damit unvermeidlich?
Z Herz-Thorax-Gefäßchir 2008;22:110-118.
45. Noyez L, Kievit PC, Swieten HA, Boer MJ.
Cardiac operative risk evaluation: The EuroScore II, does it make a real difference?
Net Heart J 2012;20:494-498.
46. Kellum JA, Venkataraman R.
Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-𝛋B DNA binding, and improves short-term survival in lethal endotoxemia.
Crit Care Med 2004;32:801-805.
47. Tonnesen E, Christensen VB, Toft P.
The role of cytokines in cardiac surgery.
International Journal of Cardiology 1996;53:1-10.
48. Bone C, Balk RA, Cerra FB, Dellinger P, Fein AM, Knaus WA.
Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.
Chest 1992;101.6:1644-1657.
49. Deppe AC, Weber C, Choi YH, Wahlers T.
Einsatz eines Zytokinfilters in die Herz-Lungen-Maschine: Modifikation der postoperativen Entzündungsreaktion.
Z Herz-Thorax-Gefäßchir 2016;30:254-259.
50. Kogelmann K, Drüner M, Jarczak D.
Case study of 8 patients with multiple organ failure treated additionally with
Cytosorbents haemadsorption as adjunctive therapy in septic shock and severe SIRS in cardiac failure.
Infection 2015;43:1.
51. Basu R, Pathak S, Goyal J, Chaudhry R, Goel RB, Barwal A.
Use of a novelhemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: a case study.
Indian J Crit Care Med 2014;18:822-824.
52. Cropsey C, Kennedy J, Han J, Pandharipande P.
Cognitive dysfunction, delirium, and stroke in cardiac surgery patients.
Seminars in Cardiothoracic and Vascular Anesthesia 2015;19:309-317.
53. Rundshagen I.
Postoperative kognitive Dysfunktion.
Dtsch Arztbl Int 2014;111(8):119-125.
54. Rudolph JL, Jones RN, Levkoff SE, Rockett C, Inouye SK, Sellke FW, Khuri SF, Lipsitz LA, Remlawi B, Levitsky S, Marcantonio ER.
Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery.
Circulation 2009;119:229-236.
55. Schmoch T, Bernhard M, Uhle F, Gründling M, Brenner T, Weigand MA.
Neue SEPSIS-3-Definition.
Anaesthesist 2017;66:614-621.
56. Sablotzki A, Mann V, Czeslick.
Eränderungen des Zytokin-Netzwerkes bei eskalierendem SIRS nach herzchirurgischen Operationen.
Anästhesiol Intensivmed Notfallmed Schmerzther 2001;36:552-559.
57. Hetz H, Berger R, Recknagel P, Steltzer H.
Septic shock secondary to b-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy.
Int J Artif Organs 2014;37(5):422-426.
58. Born F, Pichlmaier, Peterß S, Khaladj, Hagl C.
Systemic inflammatory response syndrome: Neue Therapiemöglichkeiten durch den Einsatz eines Cytokin-Adsorbers während EKZ?
Kardiotechnik 2004;2:41-46.
59. Schmidt AK, Assmann A, Lichtenberg A, Boeken U.
Systemische Inflammation und Herzchirurgie.
Z Herz-Thorax-Gefäßchir 2018;32:59-66.
60. Landis RC, Brown JR, Fitzgerald D, Likosky DS, Shore-Lesserson L, Baker RA, Hammon JW.
Attenuating the Systemic Inflammtory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence Base
The Journal of ExtraCorporeal Technology JECT.2014;197-211
61. O´Neal HR, Koyama T, Koehler EAS, Siew E, Curtis BR, Fremont RD, May AK, Bernard GR, Ware LB
Prehospital Statin and Aspirin Use and the Prevalence of Severe Sepsis and ALI/ARDS Crit Care Med.2011 June; 39(6): 1343-1350